Author Archives: Paul Older

Reference values for cardiopulmonary exercise testing in healthy adults: a systematic review

Paap, Davy; Takken, Tim.
Expert Review of Cardiovascular Therapy, December 2014, Vol. 12 Issue: Number 12 p1439-1453, 15p

Abstract: Reference values (RV) for cardiopulmonary exercise testing (CPET) provide the comparative basis for answering
important questions concerning the normality of exercise response in
patients and significantly impacts the clinical decision-making
process. The aim of this study is to systematically review the
literature on RV for CPET in healthy adults. A secondary aim is to make
appropriate recommendations for the practical use of RV for CPET.
Systematic searches of MEDLINE, EMBASE and PEDro databases up to March
2014 were performed. In the last 30 years, 35 studies with CPET RV were
published. There is no single set of ideal RV; characteristics of each
population are too diverse to pool the data in a single equation.
Therefore, each exercise laboratory must select appropriate sets of RV
that best reflect the characteristics of the population/patient tested,
and equipment and methodology utilized.

Putting lung function and physiology into perspective: cystic fibrosis in adults

Horsley, Alex; Siddiqui, Salman
Respirology, January 2015, Vol. 20 Issue: Number 1 p33-45, 13p
Abstract: Adult cystic fibrosis (CF) is notable for the wide heterogeneity in severity
of disease expression, both between patients and within the lungs of
individuals. Although CFairways disease appears to start in the small
airways, in adults there is typically widespread bronchiectasis,
increased airway secretions, and extensive obstruction and inflammation
of the small airways. The complexity and heterogeneity of airways
disease in CFmeans that although there are many different methods of
assessing and describing lung ‘function’, none of these
single‐dimensional tests is able to provide a comprehensive assessment
of lung physiology across the spectrum seen in adult CF. The most
widely described measure, the forced expiratory volume in 1 s, remains
a useful and simple clinical tool, but is insensitive to early changes
and may be dissociated from other more detailed assessments of disease
severity such as computed tomography. In this review, we also discuss
the use of more sensitive novel assessments such as multiple breath
washout tests and impulse oscillometry, as well as the role of
cardiopulmonary exercise testing. In the future, hyperpolarized gas
magnetic resonance imaging techniques that combine regional structural
and functional information may help us to better understand these
measures, their applications and limitations.;

The global peripheral chemoreflex drive in patients with systemic sclerosis: a rebreathing and exercise study

Ninaber, M.K.; Hamersma,
W.B.G.J.; Schouffoer, A.A.; van ’t Wout, E.F.A.; Stolk, J.. QJM:

An International Journal of Medicine, January 2015, Vol. 108 Issue: Number
1 p33-33, 1p;

Abstract:

Background: Exercise intolerance (EI) in
systemic sclerosis (SSc) is difficult to manage by the clinician. The
peripheral chemoreflex drive compensates for metabolic acidosis during
exercise and may be related to EI. Aim: To assess the global peripheral
chemoreflex drive (GPCD) in patients with SSc at rest and during
exercise.

Methods: Consecutively tested SSc patients (n = 49) were
evaluated by pulmonary function tests, carbon dioxide (CO2)
rebreathing studies and non-invasive cardiopulmonary exercise testing
(CPET). Results of their CO2 rebreathing tests were compared
with those of controls (n = 32). Respiratory compensation for
metabolic acidosis during CPET was defined by the occurrence of a sharp
increase in minute ventilation (VdotE) and the ventilatory equivalent
for CO2 (V’E and V’CO2) at the end of the
isocapnic buffer phase. Euoxic (eVHR) and hyperoxic (hVHR) ventilatory
responses to hypercapnia were measured and its difference (eVHR − hVHR)
was considered to reflect the GPCD. Results: In 45 patients with SSc,
CPET results showed respiratory compensation at the occurrence of
metabolic acidosis. eVHR − hVHR in patients with diffuse cutaneous SSc
(dcSSc) differed significantly from that in patients with limited
cutaneous SSc (lcSSc) and from that in controls (0.47 ± 0.38 (dcSSc)
vs. 0.90 ± 0.77 (lcSSc) and 0.90 ± 0.49 (controls) l/min/mmHg; P =
0.04 and P = 0.03, respectively).

Conclusions: Respiratory
compensation for metabolic acidosis occurred in all patients. However,
the GPCD was diminished in dcSSc patients, suggesting an altered
control of breathing. Its assessment may help the clinician to better
understand reported EI and exertional dyspnea in dcSSc patients.;

List of Practicums

CPX International (formerly ISEIRE) has been holding an annual Practicum since 1997.

London Practicum 2012

 

 

 

 

 

 

 

 

Convenor Dr M. Grocott

At this time the Board consisted of: P. Agostoni (President). K. Wasserman (Honorary President). M.Grocott, M.Riley, F Kleber ,R. Belardinelli, P. Palange, J.Hansen, P. Older.

At the Board meeting it was unanimously agreed that in the event of Dr Older being incapacitated, his daughter would temporarily take over and contact the Board to organise a permanent solution.

Sponsors were; Carefusion, Cortex, Cosmed, Medgraphics, Schiller.

 

 

Potsdam Practicum 2011

 

 

 

 

 

 

 

 

 

Convenor Dr F. Kleber

 

 

 At this time the Board consisted of: P. Agostoni (President), K. Wasserman (Honorary President),
F. Kleber, M. Riley, D. Dumitrescu, P. Palange, J. Hansen, M. Grocott, P. Older
[Professor B.Whipp had died earlier this year]

All attendees at the Practicums were automatically placed on a mailing list. Each week or so abstracts from major Journals were sent out to all on the list.
At the Board meeting it was unanimously agreed that CPX International would underwrite any losses incurred at a Practicum would be underwritten to a maximum of US$20,000

Sponsors were: Carefusion, Cortex, Cosmed, Medbgraphics, Schiller.

Bucharest Practicum 2010

 

 

 

 

 

 

 

 

Convenor Dr Miron Bogdon

 

 

 

 

 

 

 

 

 

 

At this time the Board consisted of: P. Agostoni (President), K. Wasserman (Honorary President), R. Belardinelli, A.Gitt, J. Hansen,
 F. Kleber, P. Palange, M. Riley, B. Whipp, P. Older
It was proposed and passed unaminously that Dr D. Dumitrescu be appointed a Board member
The Society name of ISEIRE was formally changed to CPX International and registered as Charity with the ACNC in Melbourne.
The website was renamed www.cpxinternational.com

Sponsors were:  Carefusion, Cortex, Cosmed, Innovision, Medgraphics, Schiller

Cologne Practicum 2009

Convened by Dr Daniel Dumitrescu

 

 

 

 

 

 

 

 

 

Board at that time was: P. Agostoni (President), K. Wasserman (Hon. President), R. Belardinelli, A. Gitt, J. Hansen, F. Kleber, P. Palange, M. Riley, B. Whipp, P. Older

There was a Board motion to change name of Society from ISEIRE to CPX International.
This motion was passed by a split vote by the Board and a majority vote by email.
Sponsors were: Cardinal Health (Sensormedics & Jaeger), Cortex, Cosmed, Innovision, Medgraphics, Schiller

Oporto Practicum 2008

 

The 12th. European Practicum held at Gaia, Oporto, Portugal
The convenor was Dr Nuno Cortesao

At that time the Board consisted of
K.Wasserman (President), P. Agostoni, A.Gitt, R. Belardinelli, J. Hansen, M. Riley, B. Whipp, D.Levett, F. Kleber, P. Older,

Sponsors were: Cardinal Health [formerly Viasys – which was Jaeger and Sensor Medics]
Cosmed, Cortex, Schiller, Medgraphics, Innovision

The Practicum was video recorded and featured simultaneous translation into English and Portugese. At that time the society was called ISEIRE and the video discs are held by CPX
International
The Board Meeting held via email on 22nd October 2008
A website www.cpxtesting .com was setup but was not detectable by a Google search for ISIERE. Later the site name was to be changed to www.cpxinternational.com